Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10403-51-7

Post Buying Request

10403-51-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4,8-Ethenopyrrolo[3',4':3,4]cyclobut[1,2-f]isoindole-1,3,5,7(2H,6H)-tetrone,3a,3b,4,4a,7a,8,8a,8b-octahydro-, (3aR,3bS,4R,4aR,7aS,8S,8aR,8bS)-rel-

    Cas No: 10403-51-7

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • 4,8-Ethenopyrrolo[3',4':3,4]cyclobut[1,2-f]isoindole-1,3,5,7(2H,6H)-tetrone,3a,3b,4,4a,7a,8,8a,8b-octahydro-, (3aR,3bS,4R,4aR,7aS,8S,8aR,8bS)-rel- cas 10403-51-7

    Cas No: 10403-51-7

  • No Data

  • No Data

  • No Data

  • Hangzhou Fandachem Co.,Ltd
  • Contact Supplier

10403-51-7 Usage

General Description

Mitindomide is a chemical compound that belongs to the class of immunomodulatory drugs. It is being investigated for its potential use in the treatment of autoimmune diseases, inflammatory conditions, and cancers. Mitindomide works by modulating the immune system and reducing inflammation. It has shown promising results in preclinical studies and is currently in phase I/II clinical trials for the treatment of multiple myeloma, a type of blood cancer. Mitindomide has the potential to provide a new treatment option for patients with various immune-related and cancerous conditions. However, further research and clinical trials are needed to fully understand its safety and efficacy.

Check Digit Verification of cas no

The CAS Registry Mumber 10403-51-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,0 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10403-51:
(7*1)+(6*0)+(5*4)+(4*0)+(3*3)+(2*5)+(1*1)=47
47 % 10 = 7
So 10403-51-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H12N2O4/c17-11-7-3-1-2-4(8(7)12(18)15-11)6-5(3)9-10(6)14(20)16-13(9)19/h1-10H,(H,15,17,18)(H,16,19,20)

10403-51-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Mitindomide

1.2 Other means of identification

Product number -
Other names Benzenebismaleimide adduct

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10403-51-7 SDS

10403-51-7Downstream Products

10403-51-7Related news

Kinetics of hydrolysis of fetindomide (NSC-373965), bis-N,N′-phenylalanyloxymethyl prodrug of Mitindomide (cas 10403-51-7) (NSC-284356); an unexpected catalytic effect of generated formaldehyde07/31/2019

The degradation kinetics of fetindomide, a potential prodrug of mitindomide, was studied in aqueous solution at 25°C. The hydrolysis of dilute fetindomide solutions maintained between pH 2.5 and 4.5 followed apparent first-order kinetics over several half-lives. At higher pH values (5.0–8.5) t...detailed

Stability indicating assay for fetindomide (NSC 373965), a potential prodrug of Mitindomide (cas 10403-51-7) (NSC 284356), employing high-performance liquid chromatography07/30/2019

A stability indicating assay for fetindomide using reversed-phase high-performance liquid chromatography (HPLC) has been developed. The chromatography was performed on a MOS Hypersil (C8) column and was optimized by investigating the effects of methanol (7.5–20%), acetonitrile (5–7%), tetrabut...detailed

10403-51-7Relevant articles and documents

Synthesis of Congeners and Prodrugs of the Benzene Maleimide Photoadduct Mitindomide as Potential Antitumor Agents. 2

Deutsch, Howard M.,Gelbaum, Leslie T.,McLaughlin, Mark,Fleischmann, Thomas J.,Earnhart, Lawrence L.,et al.

, p. 2164 - 2170 (1986)

Potential prodrugs of the highly insoluble, diimide antitumor agent mitindomide (1b) were synthesized by several different methods.The condensation reaction between mitindomide and formaldehyde cleanly gave the stable bis(hydroxymethyl) compound 7a, which was partially soluble in water (ca. 0.8percent) and showed improved activity in the P-388 screen.When this compound was treated with secondary amines, good yields of Mannich bases could be isolated.The compound from N-methylpiperazine (7b) had excellent properties and is a candidate for clinical trials.Condensation with other aldehydes gave either no reaction or compounds with poor activity.A water-soluble ester was prepared from 7a and succinic anhydride, but had reduced potency and activity.Oxidation of the double bond of 1a with ozone gave an inactive diacid, whereas the dihydro compound was as active as the olefin.When other aromatics (anisole, p-xylene, mesitylene) were photolyzed with maleimide, the resulting photoproducts were found to be inactive.Diimides from other ring system were synthesized from the corresponding anhydrides and found to be inactive, However, the bis(hydroxymethyl) derivative of one of these (12a) was active in the P-388 screen.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10403-51-7